At a glance
- Originator Nonindustrial source
- Class
- Mechanism of Action Chelating agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Iron overload
Most Recent Events
- 28 Jun 2001 No-Development-Reported for Iron overload in United Kingdom (Unknown route)
- 20 Feb 1997 Preclinical development for Iron overload in United Kingdom (Unknown route)